IBM shares tank despite upbeat Q1 earnings. Analysts maintain Buy rating and $270 price target. Stock decline appears overdone.
Latest Ratings for IBM
DateFirmActionFromTo Jan 2022BMO CapitalMaintainsMarket Perform Jan 2022UBSDowngradesNeutralSell Jan 2022Goldman SachsInitiates Coverage OnNeutral